A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function - No Study Results Posted

A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function (HORIZON-HF)

This study has been completed.

Study NCT00616161 Information provided by sigma-tau i.f.r. S.p.A.

First Received: February 5, 2008 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2007
Primary Completion Date:	July 2007 (Final data collection date for primary outcome measure)